ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4 | -20.0% | 8,211 | 0.0% | 0.00% | – |
| Q1 2023 | $5 | 0.0% | 8,211 | 0.0% | 0.00% | – |
| Q4 2022 | $5 | -100.0% | 8,211 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $14,000 | +40.0% | 8,211 | -2.1% | 0.00% | 0.0% |
| Q2 2022 | $10,000 | +100.0% | 8,383 | +1.9% | 0.00% | – |
| Q1 2022 | $5,000 | -80.0% | 8,227 | -63.9% | 0.00% | -100.0% |
| Q4 2021 | $25,000 | -44.4% | 22,813 | -7.0% | 0.00% | -50.0% |
| Q3 2021 | $45,000 | -32.8% | 24,522 | -3.3% | 0.00% | -33.3% |
| Q2 2021 | $67,000 | -26.4% | 25,351 | 0.0% | 0.00% | -40.0% |
| Q1 2021 | $91,000 | +40.0% | 25,351 | -2.0% | 0.01% | +25.0% |
| Q4 2020 | $65,000 | -3.0% | 25,858 | -2.3% | 0.00% | 0.0% |
| Q3 2020 | $67,000 | -23.0% | 26,473 | +0.3% | 0.00% | -33.3% |
| Q2 2020 | $87,000 | +29.9% | 26,386 | -3.1% | 0.01% | 0.0% |
| Q1 2020 | $67,000 | -48.9% | 27,233 | -2.0% | 0.01% | -33.3% |
| Q4 2019 | $131,000 | – | 27,796 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $51,946,000 | 2.80% |
| MILLER VALUE PARTNERS, LLC | 4,900,721 | $26,219,000 | 1.15% |
| MSD Partners, L.P. | 3,410,500 | $18,246,000 | 0.92% |
| Michael & Susan Dell Foundation | 66,749 | $357,000 | 0.26% |
| Glacier Peak Capital LLC | 68,043 | $364,000 | 0.21% |
| Vident Investment Advisory, LLC | 114,980 | $615,000 | 0.08% |
| SFMG, LLC | 62,433 | $334,000 | 0.07% |
| Virtus ETF Advisers LLC | 40,359 | $216,000 | 0.06% |
| Steward Partners Investment Advisory, LLC | 23,187 | $124,000 | 0.06% |
| O'Dell Group, LLC | 10,142 | $54,000 | 0.05% |